Fragment docking to S100 proteins reveals a wide diversity of weak interaction sites. (Q33294429)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17705319%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

title

Fragment docking to S100 proteins reveals a wide diversity of weak interaction sites (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17705319%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17705319%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Claudio Luchinat

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17705319%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Mattia Mori

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17705319%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

3

Rebecca Del Conte

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17705319%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

author name string

Yvonne Arendt

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17705319%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Marco Porcu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17705319%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

publication date

1 November 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17705319%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17705319%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17705319%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

page(s)

1648-1654

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17705319%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17705319%20AND%20SRC:MED&resulttype=core&format=json

The S100 family of EF-hand calcium-binding proteins: functions and pathology

3 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700096

Calcium and S100B regulation of p53-dependent cell growth arrest and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700096

Concerted regulation of wild-type p53 nuclear accumulation and activation by S100B and calcium-dependent protein kinase C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700096

Intracellular and extracellular roles of S100 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700096

7 January 2021

The S100 protein family: history, function, and expression

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700096

7 January 2021

S100A13. Biochemical characterization and subcellular localization in different cell lines

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700096

7 January 2021

Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700096

7 January 2021

S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700096

7 January 2021

Molecular mechanisms of S100-target protein interactions

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700096

7 January 2021

Synthetic ligands able to interact with the p53 tetramerization domain. Towards understanding a protein surface recognition event

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700096

7 January 2021

Inhibition of protein-protein interactions: The discovery of druglike β-catenin inhibitors by combining virtual and biophysical screening

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700096

7 January 2021

Future challenges facing the development of specific active-site-directed synthetic inhibitors of MMPs

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700096

7 January 2021

Structure- and fragment-based approaches to protease inhibition

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700096

7 January 2021

Calcium-dependent interaction of S100B with the C-terminal domain of the tumor suppressor p53.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700096

7 January 2021

The Ca(2+)-dependent interaction of S100B(beta beta) with a peptide derived from p53

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700096

7 January 2021

Structural changes in the C-terminus of Ca2+-bound rat S100B (beta beta) upon binding to a peptide derived from the C-terminal regulatory domain of p53.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700096

7 January 2021

Structure of the negative regulatory domain of p53 bound to S100B(betabeta)

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700096

7 January 2021

Proteins of the S100 family regulate the oligomerization of p53 tumor suppressor

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700096

7 January 2021

Inhibition of p53 transcriptional activity by the S100B calcium-binding protein.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700096

7 January 2021

Inhibiting S100B restores p53 levels in primary malignant melanoma cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700096

7 January 2021

Recognition of the tumor suppressor protein p53 and other protein targets by the calcium-binding protein S100B

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700096

7 January 2021

S100A13, a new marker of angiogenesis in human astrocytic gliomas.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700096

7 January 2021

The intracellular translocation of the components of the fibroblast growth factor 1 release complex precedes their assembly prior to export

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700096

7 January 2021

The non-classical export routes: FGF1 and IL-1alpha point the way.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700096

7 January 2021

The C2A domain of synaptotagmin exhibits a high binding affinity for copper: implications in the formation of the multiprotein FGF release complex

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700096

7 January 2021

Development of molecular probes for second-site screening and design of protein tyrosine phosphatase inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700096

7 January 2021

TINS, target immobilized NMR screening: an efficient and sensitive method for ligand discovery

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700096

7 January 2021

Development of a dual cell, flow-injection sample holder, and NMR probe for comparative ligand-binding studies

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700096

7 January 2021

Second-site NMR screening and linker design

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700096

7 January 2021

Protein NMR in biomedical research

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700096

7 January 2021

NMR-based methods and strategies for drug discovery.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700096

7 January 2021

WaterLOGSY as a method for primary NMR screening: practical aspects and range of applicability.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700096

7 January 2021

Two distinct anti-allergic drugs, amlexanox and cromolyn, bind to the same kinds of calcium binding proteins, except calmodulin, in bovine lung extract

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700096

7 January 2021

Three distinct anti-allergic drugs, amlexanox, cromolyn and tranilast, bind to S100A12 and S100A13 of the S100 protein family

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700096

7 January 2021

Ligand efficiency: a useful metric for lead selection

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700096

7 January 2021

The maximal affinity of ligands

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700096

7 January 2021

Fragment-based lead discovery: leads by design

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700096

7 January 2021

FAST-NMR: functional annotation screening technology using NMR spectroscopy

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700096

7 January 2021

Druggability indices for protein targets derived from NMR-based screening data

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700096

7 January 2021

Cytochrome c and organic molecules: solution structure of the p-aminophenol adduct

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700096

7 January 2021

Structural interplay between calcium(II) and copper(II) binding to S100A13 protein

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700096

7 January 2021

Nuclear magnetic resonance assignments and secondary structure of bovine S100β protein

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700096

7 January 2021

The solution structure of HIV-1 Nef reveals an unexpected fold and permits delineation of the binding surface for the SH3 domain of Hck tyrosine protein kinase

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700096

7 January 2021